Fig. 4From: Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trialFacial angiofibromas of a Patient with the Tuberous Sclerosis Complex. Panel a shows the facial angiofibromas at baseline. Panel b shows the facial angiofibromas improvement after 12 months of everolimus therapyBack to article page